Apimeds Pharmaceuticals US (APUS) to Raise $20 Million in IPO
Apimeds Pharmaceuticals US (APUS) expects to raise $20 million in an initial public offering on the week of May 12th, IPO Scoop reports. The company plans to issue 4,500,000 shares at a price of $4.00-$5.00 per share. Apimeds Pharmaceuticals US has a market cap of $57.1 million. D. Boral Capital (ex-EF Hutton) served as the […]
Apimeds Pharmaceuticals US (APUS) expects to raise $20 million in an initial public offering on the week of May 12th, IPO Scoop reports. The company plans to issue 4,500,000 shares at a price of $4.00-$5.00 per share. Apimeds Pharmaceuticals US has a market cap of $57.1 million. D. Boral Capital (ex-EF Hutton) served as the […]
